An analysis of teams facing off against pass funnel and run funnel defenses in Week 5, and what it might mean for your ...
In June 2025, the FDA granted Fast Track designation to nuvisertib, a PIM1 kinase inhibitor from Sumitomo Pharma, for ...
DelveInsight’s “Crohn's Disease Market Insights, Epidemiology, and Market Forecast–2034” provides a comprehensive analysis of ...